Ignite Creation Date:
2024-05-06 @ 2:52 PM
Last Modification Date:
2024-10-26 @ 1:39 PM
Study NCT ID:
NCT04457180
Status:
COMPLETED
Last Update Posted:
2022-10-26
First Post:
2020-06-30
Brief Title:
A Pharmacokinetic Interaction Study Between Apatinib Mesylate and Repaglinide or Bupropion in Advanced Solid Tumor Subjects
Sponsor:
Jiangsu HengRui Medicine Co Ltd
Organization:
Jiangsu HengRui Medicine Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-11-16
Start Date Type:
ACTUAL
Primary Completion Date:
2021-05-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-06-19
Completion Date Type:
ACTUAL
First Submit Date:
2020-06-30
First Submit QC Date:
June 30 2020
Study First Post Date:
2020-07-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-10-24
Last Update Post Date:
2022-10-26
Last Update Post Date Type:
ACTUAL